Monitoring vancomycin serum concentrations in cancer patients undergoing cytotoxic chemotherapy.
Kremery
V
V
Netriova
D
D
Studena
M
M
Halko
J
J
D000900:Anti-Bacterial Agents / Q000097:blood* / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D007262:Infusions, Intravenous; D008991:Monitoring, Physiologic; D009369:Neoplasms / Q000188:drug therapy; D009503:Neutropenia / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D011379:Prognosis; D014640:Vancomycin / Q000009:adverse effects / Q000097:blood* / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D014640:Vancomycin